SCHEMBL21204321

SCHEMBL21204321

CC1CCN(C)C(C(C)(C)O)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19801474 0.81 — —
SCHEMBL22789217 0.76 — —
SCHEMBL21781728 0.76 — —
SCHEMBL25706031 0.76 — —
SCHEMBL15314571 0.73 CHRM2 (0.34) —
SCHEMBL12210533 0.73 CHRM2 (0.34) —
SCHEMBL8320351 0.73 CHRM2 (0.34) —
SCHEMBL3944984 0.72 — —
SCHEMBL3944983 0.72 — —
SCHEMBL24003182 0.71 CYP1A2 (0.35) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3517536-A1 AMINOTRIAZINE DERIVATIVES USEFUL AS TANK-BINDING KINASE INHIBITOR COMPOUNDS Gilead Sciences, Inc. (US) 2019-07-31 — — EP disclosed
Send feedback